Furthermore, accumulating evidence suggests that increased BDNF signaling could improve cognition in Alzheimer’s disease [12, 15], indicating that positive modulation of NGF and BDNF signaling may be a relevant strategy to develop new treatment options for Alzheimer’s disease and other conditions where cognition is impaired. The gene discussed is NGF; the disease is Alzheimer disease.